A Metin Gulmezoglu
Overview
Explore the profile of A Metin Gulmezoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
177
Citations
11774
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen P, Sanderson B, Makama M, Mills K, Ammerdorffer A, Gulmezoglu A, et al.
BJOG
. 2025 Mar;
PMID: 40025969
Objectives: To evaluate the effects of polyphenol-containing products during pregnancy on preeclampsia-related maternal and neonatal outcomes. Design: Systematic review and meta-analysis. Setting: Nine databases and one trial registry, from inception...
2.
Bohren M, Miller S, Mammoliti K, Galadanci H, Fawcus S, Moran N, et al.
Lancet Glob Health
. 2025 Jan;
13(2):e329-e344.
PMID: 39890233
Background: Postpartum haemorrhage is a leading cause of maternal mortality. A multicountry, cluster-randomised trial (E-MOTIVE) demonstrated a 60% reduction in adverse postpartum haemorrhage outcomes. The E-MOTIVE intervention included early postpartum...
3.
Shankar M, Charantimath U, Dandappanavar A, Hazfiarini A, Pujar Y, Somannavar M, et al.
BJOG
. 2025 Jan;
PMID: 39871821
Objective: To explore factors affecting participation of pregnant women in randomised clinical trials in Belagavi, Karnataka, India. Design: A qualitative study using semi-structured in-depth interviews and focus group discussions as...
4.
Makama M, McDougall A, Cao J, Mills K, Nguyen P, Hastie R, et al.
BJOG
. 2025 Jan;
PMID: 39800868
Background: Evidence suggests L-arginine may be effective at reducing pre-eclampsia and related outcomes. However, whether L-arginine can prevent or only treat pre-eclampsia, and thus the target population and timing of...
5.
Endler M, Jaisamrarn U, Mittal S, Phanupong P, Du D, Ngo T, et al.
Lancet Glob Health
. 2024 Dec;
13(1):e112-e120.
PMID: 39706648
Background: Optimising management of second-trimester medical abortion is important, as complications increase with gestational age. We aimed to compare a 24-h interval with a 48-h interval between mifepristone intake and...
6.
Shankar M, Gulmezoglu A, Vogel J, Goudar S, McDougall A, Somannavar M, et al.
Commun Med (Lond)
. 2024 Dec;
4(1):260.
PMID: 39643638
No abstract available.
7.
Shankar M, Gulmezoglu A, Vogel J, Goudar S, McDougall A, Somannavar M, et al.
Commun Med (Lond)
. 2024 Oct;
4(1):211.
PMID: 39443672
Systematic under-representation of pregnant women and gender diverse pregnant people in clinical research has prevented them from benefitting fairly from biomedical advances. The resulting lack of pharmacological safety and efficacy...
8.
Mills K, McDougall A, Tan A, Makama M, Nguyen P, Armari E, et al.
Am J Obstet Gynecol MFM
. 2024 Sep;
6(10):101478.
PMID: 39222843
Objective: This systematic review evaluated the available evidence on the effects of proton pump inhibitors during pregnancy on preeclampsia and related maternal, fetal, and neonatal outcomes. Data Sources: Five electronic...
9.
Bautista K, Lee Y, Higgins C, Procter P, Rushwan S, Baidoo A, et al.
PLOS Glob Public Health
. 2024 Jun;
4(6):e0003181.
PMID: 38900726
Uterotonics are essential in preventing postpartum hemorrhage (PPH), the leading direct cause of maternal death worldwide. However, uterotonics are often substandard in low- and middle-income countries, contributing to poor maternal...
10.
Ammerdorffer A, McDougall A, Tuttle A, Rushwan S, Chinery L, Vogel J, et al.
Lancet Glob Health
. 2024 Jun;
12(7):e1174-e1183.
PMID: 38876763
We developed a comprehensive database of medicines that are used or are being investigated for pre-eclampsia or eclampsia, preterm birth or labour, postpartum haemorrhage, intrauterine growth restriction, and fetal distress...